Advertisement
SKIP ADVERTISEMENT
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
This X-ray shows stage 1 cancer. Summit Therapeutics of Florida had been seeking to bring to the U.S. market a drug for lung cancer, called ivonescimab, that was invented in China. Credit... James Cavallini/Universal Images Group, via Getty Images
Nov. 15, 2026, 3:33 p.m. ET
The Food and Drug Administration rejected a first-of-its-kind cancer drug that was invented in China, a setback for a medicine that had become a symbol of China’s ascendance as a powerhouse in drug development.
Summit Therapeutics, the Florida company that has been seeking to bring the drug to the American market, disclosed the agency’s decision in a news release on Sunday . Summit bought the U.S.…